| P2093 | author name string | Ulrich L M Eisel | |
| | Regien G Schoemaker | |
| | Peter Hoogerhout | |
| | Leonie Gouweleeuw | |
| | Elly van Riet | |
| | Klaske Oberman | |
| P2860 | cites work | The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide | Q21090025 |
| | The importance of neuritic plaques and tangles to the development and evolution of AD | Q22241659 |
| | Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior | Q24645994 |
| | The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 |
| | Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization | Q28185520 |
| | Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus | Q28592777 |
| | A cyclic undecamer peptide mimics a turn in folded Alzheimer amyloid β and elicits antibodies against oligomeric and fibrillar amyloid and plaques | Q28740910 |
| | High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation | Q29616564 |
| | Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse | Q29619237 |
| | Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer's disease are independent of caspase cleavage of the amyloid precursor protein | Q30499149 |
| | A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease | Q33292093 |
| | [Hippocampal and cognitive alterations precede amyloid deposition in a mouse model for Alzheimer's disease]. | Q50782883 |
| | Microglia in Alzheimer's disease | Q56922819 |
| | Evaluation of the safety and immunogenicity of synthetic A 42 (AN1792) in patients with AD | Q58005269 |
| | Recent advancements toward therapeutic vaccines against Alzheimer’s disease | Q59291648 |
| | A vaccine against Alzheimer`s disease: anything left but faith? | Q90334385 |
| | The Time Course of Recognition Memory Impairment and Glial Pathology in the hAPP-J20 Mouse Model of Alzheimer's Disease | Q91984521 |
| | Frustrated Alzheimer's researchers seek better lab mice | Q93350912 |
| | Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. | Q34417339 |
| | Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models | Q34418781 |
| | Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease. | Q34656208 |
| | Competitive short-term and long-term memory processes in spatial habituation | Q34898346 |
| | Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain | Q34979751 |
| | A fresh perspective from immunologists and vaccine researchers: active vaccination strategies to prevent and reverse Alzheimer's disease | Q36240389 |
| | Immunization with Small Amyloid-β-derived Cyclopeptide Conjugates Diminishes Amyloid-β-Induced Neurodegeneration in Mice | Q37053799 |
| | Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease | Q37118356 |
| | Gamma-secretase catalyzes sequential cleavages of the AbetaPP transmembrane domain. | Q37394529 |
| | Regulatory T cell memory | Q37420611 |
| | Spatial working memory deficits in GluA1 AMPA receptor subunit knockout mice reflect impaired short-term habituation: evidence for Wagner's dual-process memory model | Q37720835 |
| | Vaccination against Alzheimer disease: an update on future strategies | Q38188866 |
| | The Prevalence and Incidence of Dementia Due to Alzheimer's Disease: a Systematic Review and Meta-Analysis | Q38852543 |
| | The road to restoring neural circuits for the treatment of Alzheimer's disease | Q39004340 |
| | Postoperative cognitive dysfunction: Involvement of neuroinflammation and neuronal functioning. | Q39252205 |
| | Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease | Q41753192 |
| | Intracellular oligomeric amyloid-beta rapidly regulates GluA1 subunit of AMPA receptor in the hippocampus. | Q41975566 |
| | UB-311, a novel UBITh® amyloid β peptide vaccine for mild Alzheimer's disease | Q42655652 |
| | Enoxaparin treatment administered at both early and late stages of amyloid β deposition improves cognition of APPswe/PS1dE9 mice with differential effects on brain Aβ levels | Q42987394 |
| | Beta-amyloid monomers are neuroprotective. | Q43285309 |
| | A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease | Q47583762 |
| | Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease | Q47839532 |
| | Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model | Q48472347 |
| | Cognitive phenotyping of amyloid precursor protein transgenic J20 mice | Q48752053 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | spatial memory | Q3560550 |
| | Alzheimer's disease | Q11081 |
| P304 | page(s) | 261-280 | |
| P577 | publication date | 2020-07-23 | |
| P1433 | published in | Journal of Alzheimer's disease reports | Q96319946 |
| P1476 | title | Vaccination Prevented Short-Term Memory Loss, but Deteriorated Long-Term Spatial Memory in Alzheimer's Disease Mice, Independent of Amyloid-β Pathology | |
| P478 | volume | 4 | |